Melanoma-Associated Retinopathy (MAR)

  • Jose S. PulidoEmail author
Living reference work entry


Melanoma associated retinopathy is a rare paraneoplastic syndrome that occurs in patients with cutaneous or systemic melanoma. This condition usually presents with a quiet posterior segment, vascular attenuation, and visual field changes. Immunological changes in this condition lead to characteristic absence of B waves on electroretinography. Diagnosis of melanoma associated retinopathy is relevant because re-staging of the disease and change in the management may be required. In the index chapter, a case of melanoma associated retinopathy has been illustrated.


Cutaneous Melanoma Gamma Globulin Night Blindness Systemic Immunosuppression BRAF Wild Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. Bahig H, Wein F, Del Maestro RF. Melanoma-associated retinopathy report of a case and review. Can J Neurol Sci. 2011;38:797–8.CrossRefPubMedGoogle Scholar
  2. Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol. 2013;58(5):430–58.CrossRefPubMedGoogle Scholar
  3. Audemard A, de Raucourt S, Miocque S, Comoz F, Giraud JM, Dreno B, Bienvenu B, Rogerie MJ, Dompmartin A. Melanoma-associated retinopathy treated with ipilimumab therapy. Dermatology. 2013;227(2):146–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Departments of Ophthalmology and Molecular MedicineMayo ClinicRochesterUSA

Personalised recommendations